477 related articles for article (PubMed ID: 24677197)
1. Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.
Fuchs BC; Hoshida Y; Fujii T; Wei L; Yamada S; Lauwers GY; McGinn CM; DePeralta DK; Chen X; Kuroda T; Lanuti M; Schmitt AD; Gupta S; Crenshaw A; Onofrio R; Taylor B; Winckler W; Bardeesy N; Caravan P; Golub TR; Tanabe KK
Hepatology; 2014 Apr; 59(4):1577-90. PubMed ID: 24677197
[TBL] [Abstract][Full Text] [Related]
2. Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factor.
Fujii T; Fuchs BC; Yamada S; Lauwers GY; Kulu Y; Goodwin JM; Lanuti M; Tanabe KK
BMC Gastroenterol; 2010 Jul; 10():79. PubMed ID: 20618941
[TBL] [Abstract][Full Text] [Related]
3. Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis.
Schiffer E; Housset C; Cacheux W; Wendum D; Desbois-Mouthon C; Rey C; Clergue F; Poupon R; Barbu V; Rosmorduc O
Hepatology; 2005 Feb; 41(2):307-14. PubMed ID: 15660382
[TBL] [Abstract][Full Text] [Related]
4. β-PDGF receptor expressed by hepatic stellate cells regulates fibrosis in murine liver injury, but not carcinogenesis.
Kocabayoglu P; Lade A; Lee YA; Dragomir AC; Sun X; Fiel MI; Thung S; Aloman C; Soriano P; Hoshida Y; Friedman SL
J Hepatol; 2015 Jul; 63(1):141-7. PubMed ID: 25678385
[TBL] [Abstract][Full Text] [Related]
5. Administration of Steamed and Freeze-Dried Mature Silkworm Larval Powder Prevents Hepatic Fibrosis and Hepatocellular Carcinogenesis by Blocking TGF-β/STAT3 Signaling Cascades in Rats.
Lee DY; Yun SM; Song MY; Ji SD; Son JG; Kim EH
Cells; 2020 Feb; 9(3):. PubMed ID: 32121064
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivation.
Crouchet E; Li S; Sojoodi M; Bandiera S; Fujiwara N; El Saghire H; Zhu S; Qian T; Rasha FA; Del Zompo F; Barrett SC; Schaeffer E; Oudot MA; Ponsolles C; Durand SC; Ghoshal S; Arora G; Giannone F; Chung RT; Slovic N; Van Renne N; Felli E; Pessaux P; Lupberger J; Pochet N; Schuster C; Tanabe KK; Hoshida Y; Fuchs BC; Baumert TF
JCI Insight; 2022 Jul; 7(13):. PubMed ID: 35801591
[TBL] [Abstract][Full Text] [Related]
7. Brivanib attenuates hepatic fibrosis in vivo and stellate cell activation in vitro by inhibition of FGF, VEGF and PDGF signaling.
Nakamura I; Zakharia K; Banini BA; Mikhail DS; Kim TH; Yang JD; Moser CD; Shaleh HM; Thornburgh SR; Walters I; Roberts LR
PLoS One; 2014; 9(4):e92273. PubMed ID: 24710173
[TBL] [Abstract][Full Text] [Related]
8. Pioglitazone Reduces Hepatocellular Carcinoma Development in Two Rodent Models of Cirrhosis.
Li S; Ghoshal S; Sojoodi M; Arora G; Masia R; Erstad DJ; Lanuti M; Hoshida Y; Baumert TF; Tanabe KK; Fuchs BC
J Gastrointest Surg; 2019 Jan; 23(1):101-111. PubMed ID: 30367397
[TBL] [Abstract][Full Text] [Related]
9. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
[TBL] [Abstract][Full Text] [Related]
10. EGF neutralization antibodies attenuate liver fibrosis by inhibiting myofibroblast proliferation in bile duct ligation mice.
Xu H; Liu L; Cong M; Liu T; Sun S; Ma H; You H; Jia J; Wang P
Histochem Cell Biol; 2020 Jul; 154(1):107-116. PubMed ID: 32180004
[TBL] [Abstract][Full Text] [Related]
11. Docetaxel-carboxymethylcellulose nanoparticles ameliorate CCl
Chang CC; Yang Y; Gao DY; Cheng HT; Hoang B; Chao PH; Chen LH; Bteich J; Chiang T; Liu JY; Li SD; Chen Y
J Drug Target; 2018; 26(5-6):516-524. PubMed ID: 29251522
[TBL] [Abstract][Full Text] [Related]
12. PSMP/MSMP promotes hepatic fibrosis through CCR2 and represents a novel therapeutic target.
She S; Wu X; Zheng D; Pei X; Ma J; Sun Y; Zhou J; Nong L; Guo C; Lv P; Song Q; Zheng C; Liang W; Huang S; Li Q; Liu Z; Song Z; Li Y; Zhang Y; Kong W; You H; Xi J; Wang Y
J Hepatol; 2020 Mar; 72(3):506-518. PubMed ID: 31813573
[TBL] [Abstract][Full Text] [Related]
13. Epigallocatechin Gallate Induces Hepatic Stellate Cell Senescence and Attenuates Development of Hepatocellular Carcinoma.
Sojoodi M; Wei L; Erstad DJ; Yamada S; Fujii T; Hirschfield H; Kim RS; Lauwers GY; Lanuti M; Hoshida Y; Tanabe KK; Fuchs BC
Cancer Prev Res (Phila); 2020 Jun; 13(6):497-508. PubMed ID: 32253266
[TBL] [Abstract][Full Text] [Related]
14. Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression.
Lin XM; Hu L; Gu J; Wang RY; Li L; Tang J; Zhang BH; Yan XZ; Zhu YJ; Hu CL; Zhou WP; Li S; Liu JF; Gonzalez FJ; Wu MC; Wang HY; Chen L
Gastroenterology; 2017 Apr; 152(5):1187-1202. PubMed ID: 28065789
[TBL] [Abstract][Full Text] [Related]
15. Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells.
Zhang Z; Yao Z; Wang L; Ding H; Shao J; Chen A; Zhang F; Zheng S
Autophagy; 2018; 14(12):2083-2103. PubMed ID: 30081711
[TBL] [Abstract][Full Text] [Related]
16. TIMP-1 is upregulated, but not essential in hepatic fibrogenesis and carcinogenesis in mice.
Thiele ND; Wirth JW; Steins D; Koop AC; Ittrich H; Lohse AW; Kluwe J
Sci Rep; 2017 Apr; 7(1):714. PubMed ID: 28386095
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory Effect of Sestrin 2 on Hepatic Stellate Cell Activation and Liver Fibrosis.
Yang JH; Kim KM; Cho SS; Shin SM; Ka SO; Na CS; Park BH; Jegal KH; Kim JK; Ku SK; Lee HJ; Park SG; Cho IJ; Ki SH
Antioxid Redox Signal; 2019 Jul; 31(3):243-259. PubMed ID: 30909713
[No Abstract] [Full Text] [Related]
18. Fibroblast Growth Factor 9 is expressed by activated hepatic stellate cells and promotes progression of hepatocellular carcinoma.
Seitz T; Freese K; Dietrich P; Thasler WE; Bosserhoff A; Hellerbrand C
Sci Rep; 2020 Mar; 10(1):4546. PubMed ID: 32161315
[TBL] [Abstract][Full Text] [Related]
19. Erlotinib might be a double-edged sword in HCC.
Dong JZ; Wang LP; Zhang SN; Zou ZL; Lu MQ
Hepatology; 2015 Feb; 61(2):729. PubMed ID: 24798944
[No Abstract] [Full Text] [Related]
20. Selective inhibition of activated stellate cells and protection from carbon tetrachloride-induced liver injury in rats by a new PPARgamma agonist KR62776.
Bae MA; Rhee SD; Jung WH; Ahn JH; Song BJ; Cheon HG
Arch Pharm Res; 2010 Mar; 33(3):433-42. PubMed ID: 20361309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
